Targeting Phosphoglycerate Kinases by Tatridin A, a Natural Sesquiterpenoid Endowed with Anti-cancer Activity, Using a Proteomic Platform
Overview
Authors
Affiliations
Tatridin A (TatA) is a germacrane sesquiterpenoid containing one E-double bond and one Z-double bond in its 10-membered ring, which is fused to a 3-methylene-dihydrofuran-2-one moiety. Tatridin A bioactivity has been poorly investigated despite its interesting chemical structure. Here, a functional proteomic platform was adapted to disclose its most reliable targets in leukemia monocytic cells, and phosphoglycerate kinases were recognized as the most affine enzymes. Through a combination of limited proteolysis and molecular docking, it has been discovered that tatridin A interacts with the active domains of phosphoglycerate kinase 1, altering its hinge region, and it can be accountable for tatridin A inhibition potency on enzyme activity. A more detailed tatridin A biological profile showed that it is also fully active against gastric cancer cells, downregulating the mRNA levels of chemokine receptor 4 and β-catenin and inhibiting the invasiveness of living KATO III cells as a direct consequence of phosphoglycerate kinase 1 antagonism.
Markov A, Moralev A, Odarenko K Biomedicines. 2025; 13(1).
PMID: 39857717 PMC: 11761231. DOI: 10.3390/biomedicines13010133.
Saikia L, Gogoi B, Sen S, Tonk R, Kumar D, Dutta P Med Oncol. 2024; 41(7):164.
PMID: 38816663 DOI: 10.1007/s12032-024-02387-5.